Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Phase II trial design agreed for InKine's new generation purgative product

Jan. 19, 2004

Eisai assumes distribution responsibilities for Aciphex

Jan. 19, 2004

Nexium i.v. completes European MRP

Jan. 16, 2004

Actilon enters phase I for chronic HCV

Jan. 16, 2004

Novel NK1 antagonists in early development at Kyorin

Jan. 16, 2004

Second pivotal trial of methylnaltrexone for opioid-induced constipation

Jan. 15, 2004

New phase I trial for Traficet-EN

Jan. 15, 2004

Kemin Pharma develops two new molecules for HCV

Jan. 15, 2004

Sanofi-Synthelabo presents beta3-AR agonists for GI disorders and other uses

Jan. 15, 2004

Novel HCV NS5B inhibitors prepared and tested by GSK team

Jan. 14, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...